Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francoiscnon Mar 12, 2018 11:29am
217 Views
Post# 27700675

RE:francois i agree approval is coming and sp will increase

RE:francois i agree approval is coming and sp will increaseIt could go in the 2.50s too (prob not on day 1), it really depends where the big players will support it. Thomvest is pretty deep into PLI and they have deep pockets, so they could floor it as it goes up and then eventually shorts will come out and there will be an equilibrium fight. 

Analysts still have targets way beyond $3, so there is a chance we see it, it all depends on how bigger players react and how much PLI actually "pumps" the news. If they get FDA approval and release no NR for months then yea, it's not gonna hold. But if the next few weeks after they start talking partnerships, nasdaq, etc, it could keep the momentum.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse